
Excited to share our study, published today in @CCR_AACR Can we harness CD40 agonism to treat bladder cancer? And how spatial immune organization within tumors correlate with response? We report findings from a phase I trial of our Fc-engineered CD40 agonist. 🧵🪡 link 👇





















